Synaptic licenses patents to R.W.Johnson

SNAP granted non-exclusive licenses for its alpha-1 adrenergic receptors and benign prostatic hypertrophy (BPH) patents to the R.W. Johnson Pharmaceutical Research Institute, a Johnson & Johnson (JNJ)...